AAAAAA
Results:
1-14
|
Results: 14
Authors:
Basset, P
Balloux, F
Perrin, N
Citation: P. Basset et al., Testing demographic models of effective population size, P ROY SOC B, 268(1464), 2001, pp. 311-317
Authors:
Gall, AL
Ruff, M
Kannan, R
Cuniasse, P
Yiotakis, A
Dive, V
Rio, MC
Basset, P
Moras, D
Citation: Al. Gall et al., Crystal structure of the Stromelysin-3 (MMP-11) catalytic domain complexedwith a phosphinic inhibitor mimicking the transition-state, J MOL BIOL, 307(2), 2001, pp. 577-586
Authors:
Boulay, A
Masson, R
Chenard, MP
El Fahime, M
Cassard, L
Bellocq, JP
Sautes-Fridman, C
Basset, P
Rio, MC
Citation: A. Boulay et al., High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase, CANCER RES, 61(5), 2001, pp. 2189-2193
Authors:
Hagglund, AC
Basset, P
Ny, T
Citation: Ac. Hagglund et al., Stromelysin-3 is induced in mouse ovarian follicles undergoing hormonally controlled apoptosis, but this metalloproteinase is not required for follicular atresia, BIOL REPROD, 64(2), 2001, pp. 457-463
Authors:
Balleine, RL
Fejzo, MS
Sathasivam, P
Basset, P
Clarke, CL
Byrne, JA
Citation: Rl. Balleine et al., The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma, GENE CHROM, 29(1), 2000, pp. 48-57
Authors:
Noel, A
Boulay, A
Kebers, F
Kannan, R
Hajitou, A
Calberg-Bacq, CM
Basset, P
Rio, MC
Foidart, JM
Citation: A. Noel et al., Demonstration in vivo that stromelysin-3 functions through its proteolyticactivity, ONCOGENE, 19(12), 2000, pp. 1605-1612
Authors:
Teesalu, T
Masson, R
Basset, P
Blasi, F
Talarico, D
Citation: T. Teesalu et al., Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation, DEV DYNAM, 214(3), 1999, pp. 248-258
Authors:
Kannan, R
Ruff, M
Kochins, JG
Manly, SP
Stoll, I
El Fahime, M
Noel, A
Foidart, JM
Rio, MC
Dive, V
Basset, P
Citation: R. Kannan et al., Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors, PROT EX PUR, 16(1), 1999, pp. 76-83
Authors:
Asch, PH
Basset, P
Roos, M
Grosshans, E
Bellocq, JP
Cribier, B
Citation: Ph. Asch et al., Expression of stromelysin 3 in keratoacanthoma and squamous cell carcinoma, AM J DERMAT, 21(2), 1999, pp. 146-150
Authors:
Vassiliou, S
Mucha, A
Cuniasse, P
Georgiadis, D
Lucet-Levannier, K
Beau, F
Kannan, R
Murphy, G
Knauper, V
Rio, MC
Basset, P
Yiotakis, A
Dive, V
Citation: S. Vassiliou et al., Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: A structure-activity study, J MED CHEM, 42(14), 1999, pp. 2610-2620
Authors:
Schonbeck, U
Mach, F
Sukhova, GK
Atkinson, E
Levesque, E
Herman, M
Graber, P
Basset, P
Libby, P
Citation: U. Schonbeck et al., Expression of stromelysin-3 in atherosclerotic lesions: Regulation via CD40-CD40 ligand signaling in vitro and in vivo, J EXP MED, 189(5), 1999, pp. 843-853
Authors:
Luo, DC
Guerin, E
Ludwig, MG
Stoll, I
Basset, P
Anglard, P
Citation: Dc. Luo et al., Transcriptional induction of stromelysin-3 in mesodermal cells is mediatedby an upstream CCAAT/enhancer-binding protein element associated with a DNase I-hypersensitive site, J BIOL CHEM, 274(52), 1999, pp. 37177-37185
Authors:
Chenard, MP
Lutz, Y
Mechine-Neuville, A
Stoll, I
Bellocq, JP
Rio, MC
Basset, P
Citation: Mp. Chenard et al., Presence of high levels of MT1-MMP protein in fibroblastic cells of human invasive carcinomas, INT J CANC, 82(2), 1999, pp. 208-212
Authors:
Holtz, B
Cuniasse, P
Boulay, A
Kannan, R
Mucha, A
Beau, F
Basset, P
Dive, V
Citation: B. Holtz et al., Role of the S-1 ' subsite glutamine 215 in activity and specificity of stromelysin-3 by site-directed mutagenesis, BIOCHEM, 38(37), 1999, pp. 12174-12179
Risultati:
1-14
|